Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about James Lanthier

Recent news which mentions James Lanthier

Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
Tickers MSSTF
Tags USPTO psilocin Psilocybin
From Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
Tickers CYBN MSSTF
Tags Psychedelics Markets Benzinga
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Management Penny Stocks Markets
From Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
Tickers MSSTF
Tags MSP/1014 Penny Stocks Psychedelics
From Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
Tickers MSSTF
Tags Cannabis Market News James Lanthier
From Benzinga
Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development
Tickers MSSTF
Tags psychedelic medicines pharmacokinetics Drug Discovery
From Benzinga
Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014
Tickers MSSTF
Tags Psychedelics Market News Centre for Addiction and Mental Health
From Benzinga
Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders
Tickers MSSTF
Tags Penny Stocks Psychedelics Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.